Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Genetic
  • Participants: 4
  • Start Date: May 1, 2021
Phase 1 Intrathecal Lumbar Administration of AAV9/CLN7 for Treatment of CLN7 Disease
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 50
  • Start Date: March 31, 2021
A Prospective, Observational Study to Evaluate Ocular Disease Progression in Children With CLN2 Batten Disease
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 24
  • Start Date: February 1, 2021
A Safety, Tolerability, and Efficacy Study of PLX-200 in Participants With Mild-to-Moderate Juvenile Neuronal Ceroid Lipofuscinosis (CLN3) Disease
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 195
  • Start Date: February 2021
Natural History Study of Batten Disease
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug, Device
  • Participants: 35
  • Start Date: August 19, 2020
Cerliponase Alfa Observational Study
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Genetic
  • Participants: 172
  • Start Date: July 1, 2020
Using Normalization Process Theory to Evaluate Providing Pediatric Palliative Care at End-of-Life as Web-Based Training Intervention for Nurses:
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Genetic
  • Participants: 13
  • Start Date: January 24, 2020
Long-Term Follow-Up of AT-GTX-501 scAAV9 Gene Transfer in Subjects With CLN6 Batten Disease
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 30
  • Start Date: December 1, 2018
Examining Developmental Outcomes of Children Diagnosed With CLN2 Disease
Showing 1-12 of 20